Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 4
1954 1
1955 1
1957 3
1959 1
1962 1
1966 1
1972 1
1973 2
1975 1
1976 1
1977 1
1979 2
1981 2
1982 1
1983 1
1984 1
1985 1
1989 1
1990 3
1991 1
1992 4
1993 3
1994 2
1995 2
1996 6
1997 5
1998 2
1999 3
2000 3
2001 3
2002 10
2003 8
2004 4
2005 3
2006 2
2007 4
2008 6
2009 6
2010 6
2011 2
2012 2
2013 7
2014 8
2015 14
2016 16
2017 14
2018 11
2019 12
2020 17
2021 12
2022 9
2023 11
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

241 results

Results by year

Filters applied: . Clear all
Page 1
Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study.
Guillet S, Loustau V, Boutin E, Zarour A, Comont T, Souchaud-Debouverie O, Costedoat Chalumeau N, Pan-Petesch B, Gobert D, Cheze S, Viallard JF, Morin AS, Sauvetre G, Cliquennois M, Royer B, Masseau A, Terriou L, Fieschi C, Lambotte O, Girault S, Lioger B, Audia S, Sacre K, Lega JC, Langlois V, Benachi A, Orvain C, Devidas A, Humbert S, Gambier N, Ruivard M, Zarrouk V, Ebbo M, Willems L, Segaux L, Mahevas M, Haddad B, Michel M, Canoui-Poitrine F, Godeau B. Guillet S, et al. Among authors: girault s. Blood. 2023 Jan 5;141(1):11-21. doi: 10.1182/blood.2022017277. Blood. 2023. PMID: 36054922 Free PMC article.
The primary outcome was the first occurrence of ITP worsening defined by a composite end point including bleeding events and/or severe thrombocytopenia (<30 109/L) and/or ITP treatment modification. We also studied the recurrence of ITP worsening and the incidence of NI …
The primary outcome was the first occurrence of ITP worsening defined by a composite end point including bleeding events and/or severe throm …
Comité de surveillance indépendant dans les essais cliniques : de la justification scientifique à l’organisation.
Locher C, Laporte S, Derambure P, Chassany O, Girault C, Avakiantz A, Bahans C, Deplanque D, Fustier P, Germe AF, Kassaï B, Lacoste L, Petitpain N, Roustit M, Simon T, Train C, Cucherat M. Locher C, et al. Among authors: girault c. Therapie. 2024 Jan-Feb;79(1):99-110. doi: 10.1016/j.therap.2023.10.013. Epub 2023 Nov 3. Therapie. 2024. PMID: 37985309 French. No abstract available.
DARPP-32 40 years later.
Girault JA, Nairn AC. Girault JA, et al. Adv Pharmacol. 2021;90:67-87. doi: 10.1016/bs.apha.2020.09.004. Epub 2020 Dec 2. Adv Pharmacol. 2021. PMID: 33706939 Free article. Review.
High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial.
Coudroy R, Frat JP, Ehrmann S, Pène F, Decavèle M, Terzi N, Prat G, Garret C, Contou D, Gacouin A, Bourenne J, Girault C, Vinsonneau C, Dellamonica J, Labro G, Jochmans S, Herbland A, Quenot JP, Devaquet J, Benzekri D, Vivier E, Nseir S, Colin G, Thevenin D, Grasselli G, Bougon D, Assefi M, Guérin C, Lherm T, Kouatchet A, Ragot S, Thille AW; FLORALI-IM study group and the REVA Research Network. Coudroy R, et al. Among authors: girault c. Lancet Respir Med. 2022 Jul;10(7):641-649. doi: 10.1016/S2213-2600(22)00096-0. Epub 2022 Mar 21. Lancet Respir Med. 2022. PMID: 35325620 Clinical Trial.
In the HFNO alone group, patients were continuously treated by HFNO with a gas flow rate of 60 L/min or the highest tolerated. In the NIV group, patients were treated with NIV with a first session of at least 4 h, and then by sessions for a minimal duration of 12 h a day, …
In the HFNO alone group, patients were continuously treated by HFNO with a gas flow rate of 60 L/min or the highest tolerated. In the …
Electrochemical imaging of cells and tissues.
Lin TE, Rapino S, Girault HH, Lesch A. Lin TE, et al. Among authors: girault hh. Chem Sci. 2018 Apr 9;9(20):4546-4554. doi: 10.1039/c8sc01035h. eCollection 2018 May 28. Chem Sci. 2018. PMID: 29899947 Free PMC article. Review.
The emergence of Brucella canis as a public health threat in Europe: what we know and what we need to learn.
Djokic V, Freddi L, de Massis F, Lahti E, van den Esker MH, Whatmore A, Haughey A, Ferreira AC, Garofolo G, Melzer F, Sacchini F, Koets A, Wyllie S, Fontbonne A, Girault G, Vicente AF, McGiven J, Ponsart C. Djokic V, et al. Among authors: girault g. Emerg Microbes Infect. 2023 Dec;12(2):2249126. doi: 10.1080/22221751.2023.2249126. Epub 2023 Aug 31. Emerg Microbes Infect. 2023. PMID: 37649455 Free PMC article. Review.
Impact of discontinuing oxytocin in active labour on neonatal morbidity: an open-label, multicentre, randomised trial.
Girault A, Sentilhes L, Desbrière R, Berveiller P, Korb D, Bertholdt C, Carrara J, Winer N, Verspyck E, Boudier E, Barjat T, Levy G, Roth GE, Kayem G, Massoud M, Bohec C, Guerby P, Azria E, Blanc J, Heckenroth H, Rousseau J, Garabedian C, Le Ray C; collaborators of the STOPOXY trial and the Groupe de Recherche en Obstétrique et Gynécologie (GROG). Girault A, et al. Lancet. 2023 Dec 2;402(10417):2091-2100. doi: 10.1016/S0140-6736(23)01803-2. Epub 2023 Nov 9. Lancet. 2023. PMID: 37952548 Clinical Trial.
The primary outcome, neonatal morbidity, was assessed at birth using a composite variable defined by an umbilical arterial pH at birth less than 7.10, a base excess greater than 10 mmol/L, umbilical arterial lactates greater than 7 mmol/L, a 5-min Apgar score less t …
The primary outcome, neonatal morbidity, was assessed at birth using a composite variable defined by an umbilical arterial pH at birth less …
BDNF/TrkB pathway activation in D1 receptor-expressing striatal projection neurons plays a protective role against L-DOPA-induced dyskinesia.
Pelosi A, Nakamura Y, Girault JA, Hervé D. Pelosi A, et al. Among authors: girault ja. Neurobiol Dis. 2023 Sep;185:106238. doi: 10.1016/j.nbd.2023.106238. Epub 2023 Jul 24. Neurobiol Dis. 2023. PMID: 37495178 Free article.
L-DOPA-induced dyskinesia (LID) is a frequent adverse side effect of L-DOPA treatment in Parkinson's disease (PD). ...Dopamine depletion alone or acute L-DOPA treatment did not significantly increase TrkB protein levels. ...
L-DOPA-induced dyskinesia (LID) is a frequent adverse side effect of L-DOPA treatment in Parkinson's disease (PD). ...Dopamine …
[Ventilatory management of SARS-CoV-2 acute respiratory failure].
Artaud-Macari E, Le Bouar G, Maris J, Dantoing E, Vatignez T, Girault C. Artaud-Macari E, et al. Among authors: girault c. Rev Mal Respir. 2023 Nov-Dec;40(9-10):751-767. doi: 10.1016/j.rmr.2023.09.005. Epub 2023 Oct 19. Rev Mal Respir. 2023. PMID: 37865564 Review. French.
Tape-Stripping Electrochemical Detection of Melanoma.
Darvishi S, Pick H, Lin TE, Zhu Y, Li X, Ho PC, Girault HH, Lesch A. Darvishi S, et al. Among authors: girault hh. Anal Chem. 2019 Oct 15;91(20):12900-12908. doi: 10.1021/acs.analchem.9b02819. Epub 2019 Sep 26. Anal Chem. 2019. PMID: 31529964
241 results